Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
about
Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasisId4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTENId2, Id3 and Id4 overcome a Smad7-mediated block in tumorigenesis, generating TGF-β-independent melanoma.Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities.Id4 promotes cell proliferation in hepatocellular carcinoma.Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance.Id4 dependent acetylation restores mutant-p53 transcriptional activity.Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.The Id-protein family in developmental and cancer-associated pathways.Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growthID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.Contribution of Inhibitor of Differentiation and Estrogenic Endocrine Disruptors to Neurocognitive Disorders
P2860
Q26776349-844E4350-FF03-4724-BB93-D60C1D951F65Q28592943-CC5D39BC-443B-48DD-94AB-F6BC8B99B731Q33652300-18BD894D-10F4-40F2-B230-190062826620Q33977414-A9BBE694-B828-4B58-AE2F-8C0416642C17Q35618867-C9E57578-880C-44DF-8049-08BDD553BA09Q37618601-D661C524-518D-4955-80D8-A630D52261B6Q37673367-777CF67D-0A96-4D56-B718-34BE391C567CQ38762824-5CFC6C2B-9170-4D41-B50E-831E840FC98FQ38898841-967FBA68-76A2-4C0A-841F-DB981730FC55Q38966904-494B8681-C74C-48E8-91EB-2BEC31E6317AQ39037653-88CCC874-6863-48FC-8535-4D3EB4C3991BQ39044368-97B3F488-F789-4B98-A753-4E5068418DC3Q39079539-CA9632C9-1F11-4DC5-8271-F9790AB4A910Q39103288-FBA68F67-2D75-47F2-B639-91BFD4E50ADFQ39529516-40EA0480-6995-4B7D-A60E-6197000A76DBQ41554763-237FF3A5-5FC2-4954-8D15-B36AA7916DFEQ47670505-DB264B64-BD2A-470B-B0CB-27377218BE21Q48134448-EEF2F5E2-FB44-4CF6-81CA-F43E89BBF500Q48166027-BEF20A9D-7432-44A0-88A8-A3CCF585726EQ58800774-96F9A13D-3A25-4506-AE43-AB0C47D7A550
P2860
Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Id1 and Id3 expression is asso ...... referentially regulates CDKN1B
@ast
Id1 and Id3 expression is asso ...... referentially regulates CDKN1B
@en
type
label
Id1 and Id3 expression is asso ...... referentially regulates CDKN1B
@ast
Id1 and Id3 expression is asso ...... referentially regulates CDKN1B
@en
prefLabel
Id1 and Id3 expression is asso ...... referentially regulates CDKN1B
@ast
Id1 and Id3 expression is asso ...... referentially regulates CDKN1B
@en
P2093
P2860
P356
P1433
P1476
Id1 and Id3 expression is asso ...... referentially regulates CDKN1B
@en
P2093
Divya Patel
Jaideep Chaudhary
Pankaj Sharma
P2860
P304
P356
10.1002/CAM4.19
P407
P577
2012-08-28T00:00:00Z